Non-viral neuronal gene delivery mediated by the HC fragment of tetanus toxin

被引:49
作者
Knight, A
Carvajal, J
Schneider, H
Coutelle, C
Chamberlain, S
Fairweather, N
机构
[1] Univ London Imperial Coll Sci Technol & Med, Sch Med, Gene Therapy Res Grp,Sect Mol Genet, Div Biomed Sci, London, England
[2] Univ London Imperial Coll Sci Technol & Med, Sch Med, Ataxia Grp, Sect Mol Genet,Div Biomed Sci, London, England
[3] Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London, England
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1999年 / 259卷 / 03期
关键词
gene therapy; gene transfer; H-C fragment; motor neuron; tetanus toxin;
D O I
10.1046/j.1432-1327.1999.00108.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many inherited neurological diseases and cancers could potentially benefit from efficient targeted gene delivery to neurons of the central nervous system. The nontoxic fragment C (H-C) of tetanus toxin retains the specific nerve cell binding and transport properties of tetanus holotoxin. The H-C fragment has previously been used to promote the uptake of attached proteins such as horseradish peroxidase, beta-galactosidase and superoxide dismutase into neuronal cells in vitro and in vivo. We report the use of purified recombinant H-C fragment produced in yeast and covalently bound to polylysine [poly(K)] to enable binding of DNA. We demonstrate that when used to transfect cells, this construct results in nonviral gene delivery and marker gene expression in vitro in N18 RE 105 cells (a neuroblastoma x glioma mouse/rat hybrid cell line) and F98 (a glioma cell line). Transfection was dependent on H-C and was neuronal cell type specific. H-C may prove a useful targeting ligand for future neuronal gene therapy.
引用
收藏
页码:762 / 769
页数:8
相关论文
共 35 条
  • [11] Delivery of recombinant tetanus-superoxide dismutase proteins to central nervous system neurons by retrograde axonal transport
    Figueiredo, DM
    Hallewell, RA
    Chen, LL
    Fairweather, NF
    Dougan, G
    Savitt, JM
    Parks, DA
    Fishman, PS
    [J]. EXPERIMENTAL NEUROLOGY, 1997, 145 (02) : 546 - 554
  • [12] Fink DJ, 1996, ANNU REV NEUROSCI, V19, P265
  • [13] Development of an HSV-based vector for the treatment of Parkinson's disease
    Fink, DJ
    Poliani, PL
    Oligino, T
    Krisky, DM
    Goins, WF
    Glorioso, JC
    [J]. EXPERIMENTAL NEUROLOGY, 1997, 144 (01) : 103 - 112
  • [14] The transmembrane domain of diphtheria toxin improves molecular conjugate gene transfer
    Fisher, KJ
    Wilson, JM
    [J]. BIOCHEMICAL JOURNAL, 1997, 321 : 49 - 58
  • [15] ENHANCED CNS UPTAKE OF SYSTEMICALLY ADMINISTERED PROTEINS THROUGH CONJUGATION WITH TETANUS C-FRAGMENT
    FISHMAN, PS
    SAVITT, JM
    FARRAND, DA
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1990, 98 (2-3) : 311 - 325
  • [16] RETROGRADE TRANS-NEURONAL TRANSFER OF THE C-FRAGMENT OF TETANUS TOXIN
    FISHMAN, PS
    CARRIGAN, DR
    [J]. BRAIN RESEARCH, 1987, 406 (1-2) : 275 - 279
  • [17] CUZN SUPEROXIDE-DISMUTASE (SOD-1)-TETANUS TOXIN FRAGMENT-C HYBRID PROTEIN FOR TARGETED DELIVERY OF SOD-1 TO NEURONAL CELLS
    FRANCIS, JW
    HOSLER, BA
    BROWN, RH
    FISHMAN, PS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (25) : 15434 - 15442
  • [18] GOTTSCHALK S, 1996, GENE THER, V3, P48
  • [19] Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors
    Haase, G
    Kennel, P
    Vigne, E
    Akli, S
    Revah, F
    Schmalbruch, H
    Kahn, A
    [J]. NATURE MEDICINE, 1997, 3 (04) : 429 - 436
  • [20] HALPERN JL, 1993, J BIOL CHEM, V268, P11188